Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
AnYuan Zhong, Xue Pan & MinHua Shi. (2015) Expression of PD-1 by CD4+CD25+CD127low Treg cells in the peripheral blood of lung cancer patients. OncoTargets and Therapy 8, pages 1831-1833.
Read now
Read now
Dominique Cathelin, Alexandra Nicolas, André Bouchot, Jennifer Fraszczak, Jérôme Labbé & Bernard Bonnotte. (2011) Dendritic cell–tumor cell hybrids and immunotherapy: what's next?. Cytotherapy 13:7, pages 774-785.
Read now
Read now
Ravi A Madan, Jeanny B Aragon-Ching, James L Gulley & William L Dahut. (2011) From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Review of Vaccines 10:6, pages 743-753.
Read now
Read now
Ravi A Madan, Mahsa Mohebtash, Jeffrey Schlom & James L Gulley. (2010) Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opinion on Biological Therapy 10:1, pages 19-28.
Read now
Read now
Evangelia M Fatourou & John S Koskinas. (2009) Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Review of Anticancer Therapy 9:10, pages 1499-1510.
Read now
Read now
Ravi A Madan, Philip M Arlen, Mahsa Mohebtash, James W Hodge & James L Gulley. (2009) Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer. Expert Opinion on Investigational Drugs 18:7, pages 1001-1011.
Read now
Read now
. (2007) Agonistic antibodies to human glucocorticoid-induced tumor necrosis factor receptor as potential stimulators of T cell immunity for the treatment of cancer and viral infections. Expert Opinion on Therapeutic Patents 17:5, pages 567-575.
Read now
Read now
Articles from other publishers (34)
Sara Abdelal Mohammed, Helal F. Hetta, Asmaa M. Zahran, Mohammed E. M. Tolba, Rasha A. H. Attia, Hosny M. Behnsawy, Abdelazeem M. Algammal, Gaber El-Saber Batiha, Ahmed Qasem Mohammed & Alzahraa Abdelraouf Ahmad. (2023) T cell subsets, regulatory T, regulatory B cells and proinflammatory cytokine profile in Schistosoma haematobium associated bladder cancer: First report from Upper Egypt. PLOS Neglected Tropical Diseases 17:4, pages e0011258.
Crossref
Crossref
Hsin-Yu Liu, Christophe Pedros, Kok-Fai Kong, Ann J Canonigo-Balancio, Wen Xue & Amnon Altman. (2021) Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 9:9, pages e002792.
Crossref
Crossref
Furong Qin, Fan Xia, Hongli Chen, Bomiao Cui, Yun Feng, Ping Zhang, Jiao Chen & Min Luo. (2021) A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Minsig Choi & Archana Thakur. (2014) Identifying Appropriate Colorectal Cancer-Associated Antigens for the Clinical Trials. Current Colorectal Cancer Reports 11:1, pages 29-36.
Crossref
Crossref
Muzammal Hussain, Aqeel Javeed, Muhammad Ashraf, Nuha Al-Zaubai, Alastair Stewart & Muhammad Mahmood Mukhtar. (2012) Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy. Pharmacological Research 66:1, pages 7-18.
Crossref
Crossref
S M Ansell, H Tang, P J Kurtin, P A Koenig, G S Nowakowski, D A Nikcevich, G D Nelson, Z Yang, D M Grote, S C Ziesmer, P T Silberstein, C Erlichman & T E Witzig. (2011) Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma. Leukemia 26:5, pages 1046-1052.
Crossref
Crossref
Peter T ScardinoCinzia Remondo & James L Gulley. 2011. Targeted Therapies for Castration-Resistant Prostate Cancer. Targeted Therapies for Castration-Resistant Prostate Cancer
54
65
.
Wen‐Chun Chang, Chao‐Hsu Li, Su‐Cheng Huang, Daw‐Yuan Chang, Li‐Yun Chou & Bor‐Ching Sheu. (2010) Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma. Cancer 116:24, pages 5777-5788.
Crossref
Crossref
Ravi A. Madan & James L. Gulley. (2010) The Current and Emerging Role of Immunotherapy in Prostate Cancer. Clinical Genitourinary Cancer 8:1, pages 10-16.
Crossref
Crossref
Ravi A. Madan, James L. Gulley, Jackie Celestin, Philip M. Arlen & Jeffrey Schlom. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
305
319
.
Fan He, Zhishui Chen, Shengyuan Xu, Ming Cai, Min Wu, Hongzhou Li & Xiaoping Chen. (2009) Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection. Surgery 145:6, pages 663-674.
Crossref
Crossref
Bin Xiong, Gansheng Feng, Shihua Luo, Huimin Liang, Lingyun Qiu, Chuansheng Zheng, Xi Liu & Guofeng Zhou. (2008) Changes of CD4+ CD25+ regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE. Journal of Huazhong University of Science and Technology [Medical Sciences] 28:6, pages 645-648.
Crossref
Crossref
Zhao Yang, JingBo Zhang, Li Wang, YuZhang Wu & Shuguang Wang. (2008) Expression of PD-1 is up-regulated in CD4+CD25+ FoxP3+ regulatory T cell of non-responders after hepatitis B surface antigen vaccine immunization. Clinical Immunology 129:1, pages 176-177.
Crossref
Crossref
Siegfried Schulz, Ulrich Häussler, Robert Mandic, Johannes T. Heverhagen, Andreas Neubauer, Anja A. Dünne, Jochen A. Werner, Eberhard Weihe & Michael Bette. (2008) Treatment with ozone/oxygen‐pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. International Journal of Cancer 122:10, pages 2360-2367.
Crossref
Crossref
S Audia, A Nicolas, D Cathelin, N Larmonier, C Ferrand, P Foucher, A Fanton, E Bergoin, M Maynadie, L Arnould, A Bateman, B Lorcerie, E Solary, B Chauffert & B Bonnotte. (2007) Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes. Clinical and Experimental Immunology 150:3, pages 523-530.
Crossref
Crossref
Robyn S. AriasMeg L. FlanaganKeith D. MillerYu-Chih NienPeisheng HuDixon GrayLeslie A. KhawliAlan L. Epstein. (2007) RA8, A Human Anti-CD25 Antibody Against Human Treg Cells. Hybridoma 26:3, pages 119-130.
Crossref
Crossref
W Kimryn Rathmell, Caroline A Martz & Brian I Rini. (2007) Renal cell carcinoma. Current Opinion in Oncology 19:3, pages 234-240.
Crossref
Crossref
Xiu Hua Yang, Satoshi Yamagiwa, Takafumi Ichida, Yasunobu Matsuda, Satoshi Sugahara, Hisami Watanabe, Yoshinobu Sato, Toru Abo, David A. Horwitz & Yutaka Aoyagi. (2006) Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. Journal of Hepatology 45:2, pages 254-262.
Crossref
Crossref
H. Roddie, M. Klammer, C. Thomas, R. Thomson, A. Atkinson, A. Sproul, M. Waterfall, K. Samuel, J. Yin, P. Johnson & M. Turner. (2006) Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia. British Journal of Haematology 133:2, pages 152-157.
Crossref
Crossref
Clare Baecher-Allan & David E. Anderson. (2006) Regulatory cells and human cancer. Seminars in Cancer Biology 16:2, pages 98-105.
Crossref
Crossref
Guliang Xia, Robert L. Truitt & Bryon D. Johnson. (2006) Graft-versus-Leukemia and Graft-versus-Host Reactions after Donor Lymphocyte Infusion Are Initiated by Host-Type Antigen-Presenting Cells and Regulated by Regulatory T Cells in Early and Long-Term Chimeras. Biology of Blood and Marrow Transplantation 12:4, pages 397-407.
Crossref
Crossref
Aihong Liu, Peisheng Hu, Leslie A. Khawli & Alan L. Epstein. (2005) Combination B7-Fc Fusion Protein Treatment and Treg Cell Depletion Therapy. Clinical Cancer Research 11:23, pages 8492-8502.
Crossref
Crossref
Dan A. Laheru, Drew M. Pardoll & Elizabeth M. Jaffee. (2005) Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology. Molecular Cancer Therapeutics 4:11, pages 1645-1652.
Crossref
Crossref
Chie Kudo-Saito, Jeffrey Schlom, Kevin Camphausen, C. Norman Coleman & James W. Hodge. (2005) The Requirement of Multimodal Therapy (Vaccine, Local Tumor Radiation, and Reduction of Suppressor Cells) to Eliminate Established Tumors. Clinical Cancer Research 11:12, pages 4533-4544.
Crossref
Crossref
Cécile Badoual, Benoît Vingert, Nour Agueznay, Olivier Adotevi, Nacilla Haicheur, Thierry Molina, Patrick Bruneval, Wolf H Fridman & Eric Tartour. (2005) Phénotypes et fonctions des lymphocytes T en pathologie tumorale. Annales de Pathologie 25:3, pages 211-219.
Crossref
Crossref
Lars A. Ormandy, Tina Hillemann, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten & Firouzeh Korangy. (2005) Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma. Cancer Research 65:6, pages 2457-2464.
Crossref
Crossref
Jong Myun Park, Masaki Terabe, Leon T. van den Broeke, Debra D. Donaldson & Jay A. Berzofsky. (2005) Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. International Journal of Cancer 114:1, pages 80-87.
Crossref
Crossref
Milcho Mincheff, Serguei Zoubak, Iskra Altankova, Stoyan Tchakarov, Petro Pogribnyy, Yevgen Makogonenko, Chavdar Botev & Harold T Meryman. (2004) Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein. Cancer Gene Therapy 12:2, pages 185-197.
Crossref
Crossref
G�rald J. Prud'homme. (2005) DNA vaccination against tumors. The Journal of Gene Medicine 7:1, pages 3-17.
Crossref
Crossref
Andreas O. Eggert, Mads H. Andersen, Heike Voigt, David Schrama, Eckhardt Kämpgen, Per thor Straten & Jürgen C. Becker. (2004)
Characterization of mouse MAGE-derived H-2K
b
-restricted CTL epitopes
. European Journal of Immunology 34:11, pages 3285-3290.
Crossref
Crossref
Graham Pawelec. (2004) Immunotherapy and immunoselection - tumour escape as the final hurdle. FEBS Letters 567:1, pages 63-66.
Crossref
Crossref
Michael A. Morse, Timothy M. Clay & H. Kim Lyerly. 2004. Handbook of Cancer Vaccines. Handbook of Cancer Vaccines
3
10
.
Eddy C Hsueh & Donald L Morton. (2003) Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine. Seminars in Cancer Biology 13:6, pages 401-407.
Crossref
Crossref
Ludmila Müller & Graham Pawelec. (2016) Cytokines and Antitumor Immunity. Technology in Cancer Research & Treatment 2:3, pages 183-194.
Crossref
Crossref